Mesa Laboratories
MLAB
160 hedge funds and large institutions have $833M invested in Mesa Laboratories in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 64 increasing their positions, 49 reducing their positions, and 23 closing their positions.
31% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 49
22% more capital invested
Capital invested by funds: $681M → $833M (+$152M)
4.22% more ownership
Funds ownership: 91% → 95.22% (+4.2%)
9% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 23
2% less funds holding
Funds holding: 163 → 160 (-3)
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$36.8M |
| 2 |
GCM
Geneva Capital Management
Milwaukee,
Wisconsin
|
+$13.6M |
| 3 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$13.6M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.56M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.43M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MOACM
176
Mutual of America Capital Management
New York
| – | -$140K | -995 | Closed |
|
|
PHK
177
Point72 Hong Kong
Hong Kong
| – | -$76K | -543 | Closed |
|
178
DZ Bank
Frankfurt Am Main,
Germany
| – | -$56.3K | -400 | Closed |
|
|
BBHC
179
Brown Brothers Harriman & Co
New York
| – | -$9K | -65 | Closed |
|
|
WWM
180
Wolff Wiese Magana
Carslbad,
California
| – | -$7K | -48 | Closed |
|
|
SC
181
SouthState Corp
Winter Haven,
Florida
| – | -$6K | -41 | Closed |
|
|
TPCW
182
TD Private Client Wealth
New York
| – | -$282 | -2 | Closed |
|
MLAB Hedge Fund Activity: Q4 2022 in Review
160 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q4 2022, worth a combined $833M — up 22% from $681M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new MLAB positions and 23 closed out — a net gain of 2 holders — while 64 added to existing stakes and 49 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $36.8M. The largest seller was Royce & Associates, cutting an estimated $14.2M.
- 160 institutional investors held Mesa Laboratories (MLAB) as of Q4 2022, down from 163 in Q3 2022.
- Funds reported $833M of Mesa Laboratories stock for Q4 2022, up 22% quarter-over-quarter.
- 25 funds opened new Mesa Laboratories positions in Q4 2022 and 23 closed out, a net change of +2 holders.
- The largest Mesa Laboratories buyer in Q4 2022 was Morgan Stanley, an estimated $36.8M added.
- The largest Mesa Laboratories seller in Q4 2022 was Royce & Associates, an estimated $14.2M sold.
Based on aggregated 13F filings for Q4 2022.